CoChat

Deletion of CD38 and supplementation of NAD+ attenuate axon degeneration in a mouse facial nerve axotomy model

Open access

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Following facial nerve axotomy, nerve function is not fully restored even after reconstruction. This may be attributed to axon degeneration/neuronal death and sustained neuroinflammation. CD38 is an enzyme that catalyses the hydrolysis of nicotinamide adenine dinucleotide (NAD+) and is a candidate molecule for regulating neurodegeneration and neuroinflammation. In this study, we analyzed the effect of CD38 deletion and NAD+supplementation on neuronal death and glial activation in the facial nucleus in the brain stem, and on axon degeneration and immune cell infiltration in the distal portion of the facial nerve after axotomy in mice. Compared with wild-type mice, CD38 knockout (KO) mice showed reduced microglial activation in the facial nucleus, whereas the levels of neuronal death were not significantly different. In contrast, the axon degeneration and demyelination were delayed, and macrophage accumulation was reduced in the facial nerve of CD38 KO mice after axotomy. Supplementation of NAD+with nicotinamide riboside slowed the axon degeneration and demyelination, although it did not alter the level of macrophage infiltration after axotomy. These results suggest that CD38 deletion and supplementation of NAD+may protect transected axon cell-autonomously after facial nerve axotomy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-73984-3

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Changes in the facial nucleus and facial nerve structure in WT mice following facial nerve axotomy. (A) The facial nerve axotomy in mice. The trunk of the left facial nerve was severed as it exited the stylomastoid foramen. (B) Neurons of the facial nuclei stained with Cresyl violet over the course of the experiment. The area circled in white is the facial nucleus. (C) The number of surviving cells in the nucleus is shown in relationship to post-operative day (POD) 0, 1, 3, 7, 14, 28, n = 6. (D) Cross sections of facial nerves immunostained with myelin basic protein (MBP) (green) and β3-tubulin (red). The images on the right are enlarged views of the areas enclosed in white. (E,F) The number of axons (E) and myelin sheaths (F) per 1 mm2 of facial nerve sections in relationship to POD. Data are expressed as mean ± SEM. n = 5. *p < 0.05; **p < 0.01 as determined by ANOVA and post-hoc Tukey’s test. Scale bar, 100 μm.
Figure 1 Changes in the facial nucleus and facial nerve structure in WT mice following facial nerve axotomy. (A) The facial nerve axotomy in mice. The trunk of the left facial nerve was severed as it exited the stylomastoid foramen. (B) Neurons of the facial nuclei stained with Cresyl violet over the course of the experiment. The area circled in white is the facial nucleus. (C) The number of surviving cells in the nucleus is shown in relationship to post-operative day (POD) 0, 1, 3, 7, 14, 28, n = 6. (D) Cross sections of facial nerves immunostained with myelin basic protein (MBP) (green) and β3-tubulin (red). The images on the right are enlarged views of the areas enclosed in white. (E,F) The number of axons (E) and myelin sheaths (F) per 1 mm2 of facial nerve sections in relationship to POD. Data are expressed as mean ± SEM. n = 5. *p < 0.05; **p < 0.01 as determined by ANOVA and post-hoc Tukey’s test. Scale bar, 100 μm.CC BY · PubMed Central
Figure 2 Comparison of facial nerve structures between WT and CD38 knockout (KO) mice following axotomy. (A) Nissl staining of neurons in the facial nuclei from WT and CD38 KO mice. The area circled in white is the facial nucleus. (B) Time-dependent changes of the number of surviving cells on the nerve transection side (n = 4). (C) Cross sections of facial nerves on post-operative days (POD) 3 and POD7 immunostained with myelin basic protein (MBP) (green) and β3-tubulin (red). The images on the right are enlarged views of the areas enclosed in white. (D,E) The number of axons (D) and myelin sheaths (E) per 1 mm2 of facial nerve sections in relationship to POD. Data are expressed as mean ± SEM. n = 4. *p < 0.05, **p < 0.01, as determined by t-test. Scale bar, 100 μm.
Figure 2 Comparison of facial nerve structures between WT and CD38 knockout (KO) mice following axotomy. (A) Nissl staining of neurons in the facial nuclei from WT and CD38 KO mice. The area circled in white is the facial nucleus. (B) Time-dependent changes of the number of surviving cells on the nerve transection side (n = 4). (C) Cross sections of facial nerves on post-operative days (POD) 3 and POD7 immunostained with myelin basic protein (MBP) (green) and β3-tubulin (red). The images on the right are enlarged views of the areas enclosed in white. (D,E) The number of axons (D) and myelin sheaths (E) per 1 mm2 of facial nerve sections in relationship to POD. Data are expressed as mean ± SEM. n = 4. *p < 0.05, **p < 0.01, as determined by t-test. Scale bar, 100 μm.CC BY · PubMed Central
Figure 3 Comparison of time-dependent changes of glial cells and peripheral inflammatory cells between WT and CD38 CD38 knockout (KO) mice. (A) Facial nuclei from WT and CD38 KO mice immunostained with glial fibrillary acidic protein (GFAP) (green) and DAPI (blue) at post-operative day (POD) 7. Scale bar, 100 μm. (B,C) Time-dependent changes in the number (B) and the size (C) of GFAP + cells. (D) Facial nuclei from WT and CD38 KO mice immunostained with Iba1 (red) and DAPI (blue) at POD7. Scale bar, 100 μm. (E,F) Time-dependent changes in the number (E) and the size (F) of Iba1 + cells. (G,J) Cross sections of facial nerves from WT and CD38 KO mice immunostained with Iba1 (G) and Gr-1 (J) at POD1, POD3, and POD7. Scale bar, 100 μm. (H,I,K) The number (H) and the size (I) of Iba1-positive cells and the number of Gr-1-positive cells (K). Data are expressed as mean ± SEM. n = 4. *p < 0.05, **p < 0.01, as determined by t-test.
Figure 3 Comparison of time-dependent changes of glial cells and peripheral inflammatory cells between WT and CD38 CD38 knockout (KO) mice. (A) Facial nuclei from WT and CD38 KO mice immunostained with glial fibrillary acidic protein (GFAP) (green) and DAPI (blue) at post-operative day (POD) 7. Scale bar, 100 μm. (B,C) Time-dependent changes in the number (B) and the size (C) of GFAP + cells. (D) Facial nuclei from WT and CD38 KO mice immunostained with Iba1 (red) and DAPI (blue) at POD7. Scale bar, 100 μm. (E,F) Time-dependent changes in the number (E) and the size (F) of Iba1 + cells. (G,J) Cross sections of facial nerves from WT and CD38 KO mice immunostained with Iba1 (G) and Gr-1 (J) at POD1, POD3, and POD7. Scale bar, 100 μm. (H,I,K) The number (H) and the size (I) of Iba1-positive cells and the number of Gr-1-positive cells (K). Data are expressed as mean ± SEM. n = 4. *p < 0.05, **p < 0.01, as determined by t-test.CC BY · PubMed Central
Figure 4 Comparison of the NAD+ levels of the facial nuclei and nerves from WT, CD38 KO and nicotinamide riboside (NR)-administered mice. (A,B) NAD+ contents of the facial nuclei (A) and nerves (B) in WT and CD38 KO mice. (C,D) NAD+ contents of the facial nuclei (C) and nerves (D) in mice with or without NR administration, NR(+) and NR(−), respectively. Data are expressed as mean ± SEM. n = 4, *p < 0.05, **p < 0.01, as determined by t-test.
Figure 4 Comparison of the NAD+ levels of the facial nuclei and nerves from WT, CD38 KO and nicotinamide riboside (NR)-administered mice. (A,B) NAD+ contents of the facial nuclei (A) and nerves (B) in WT and CD38 KO mice. (C,D) NAD+ contents of the facial nuclei (C) and nerves (D) in mice with or without NR administration, NR(+) and NR(−), respectively. Data are expressed as mean ± SEM. n = 4, *p < 0.05, **p < 0.01, as determined by t-test.CC BY · PubMed Central
Figure 5 Effects of nicotinamide riboside (NR) administration on the facial nuclei and nerves. (A) Nissl staining of neurons in the facial nuclei of WT (NR(−)) and NR-administered WT (NR( +)) mice. The area circled in white is the facial nucleus. (B) The time-dependent changes of the number of surviving cells on the nerve transection side in NR− and NR + mice (n = 4). (C) Facial nerve cross-sections from NR − and NR + mice at POD3 and POD7 immunostained with myelin basic protein (MBP) (green) and β3-tubulin (red). The images on the right are enlarged views of the areas enclosed in white. (D,E) Time-dependent changes in the number of axons (D) and myelin sheaths (E) per mm2 in facial nerve sections. Data are expressed as mean ± SEM. n = 4. *p < 0.05, **p < 0.01, as determined by t-test. Scale bar, 100 μm.
Figure 5 Effects of nicotinamide riboside (NR) administration on the facial nuclei and nerves. (A) Nissl staining of neurons in the facial nuclei of WT (NR(−)) and NR-administered WT (NR( +)) mice. The area circled in white is the facial nucleus. (B) The time-dependent changes of the number of surviving cells on the nerve transection side in NR− and NR + mice (n = 4). (C) Facial nerve cross-sections from NR − and NR + mice at POD3 and POD7 immunostained with myelin basic protein (MBP) (green) and β3-tubulin (red). The images on the right are enlarged views of the areas enclosed in white. (D,E) Time-dependent changes in the number of axons (D) and myelin sheaths (E) per mm2 in facial nerve sections. Data are expressed as mean ± SEM. n = 4. *p < 0.05, **p < 0.01, as determined by t-test. Scale bar, 100 μm.CC BY · PubMed Central
Figure 6 Comparison of time-dependent changes of glial cells and peripheral inflammatory cells in WT mice with and without nicotinamide riboside (NR) administration. (A) Facial nuclei from WT (NR(−)) and NR-administered WT (NR( +)) mice immunostained with GFAP (green) and DAPI (blue) at POD7. Scale bar, 100 μm. (B,C) Time-dependent changes in the number (B) and the size (C) of GFAP + cells. (D) Facial nuclei of WT and NR mice immunostained with Iba1 (red) and DAPI (blue) at POD7. Scale bar, 100 μm. (E,F) Time-dependent changes in the number (E) and the size (F) of Iba1 + cells. (G,J) Cross-sections of facial nerves from WT and NR mice immunostained with Iba1 (G) and Gr-1 (J) at POD1, POD3, and POD7. (H–K) The numbers (H) and the size (I) of Iba1-positive cells and the number of Gr-1-positive cells (K). Data are expressed as mean ± SEM. n = 4, respectively. *p < 0.05, **p < 0.01, as determined by t-test.
Figure 6 Comparison of time-dependent changes of glial cells and peripheral inflammatory cells in WT mice with and without nicotinamide riboside (NR) administration. (A) Facial nuclei from WT (NR(−)) and NR-administered WT (NR( +)) mice immunostained with GFAP (green) and DAPI (blue) at POD7. Scale bar, 100 μm. (B,C) Time-dependent changes in the number (B) and the size (C) of GFAP + cells. (D) Facial nuclei of WT and NR mice immunostained with Iba1 (red) and DAPI (blue) at POD7. Scale bar, 100 μm. (E,F) Time-dependent changes in the number (E) and the size (F) of Iba1 + cells. (G,J) Cross-sections of facial nerves from WT and NR mice immunostained with Iba1 (G) and Gr-1 (J) at POD1, POD3, and POD7. (H–K) The numbers (H) and the size (I) of Iba1-positive cells and the number of Gr-1-positive cells (K). Data are expressed as mean ± SEM. n = 4, respectively. *p < 0.05, **p < 0.01, as determined by t-test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 17

Metadata

Authors
Takaso, Y., Noda, M., Hattori, T., Roboon, J., Hatano, M., Sugimoto, H., Brenner, C., Yamamoto, Y., Okamoto, H., Higashida, H., Ito, M., Yoshizaki, T., & Hori, O.
Affiliations
  • Kanazawa University (JP)
  • University of Iowa (US)
Corresponding author
Hori, Osamu
Venue
Scientific Reports
Published
2020-10-20
Volume
10
Issue
1
Pages
17795-17795
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3094620497
Cited by
17
References
56
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 1 · 2021: 2
FWCI
0.92
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Kanazawa University SAKIGAKE Project 2018 and the CHOZEN project
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Health Sciences › Medicine › Clinical Neurology › Facial Nerve Paralysis Treatment and Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
CD38, NAD+ supplementation, nicotinamide riboside, axonal degeneration, facial nerve axotomy, demyelination, microglial activation, macrophage infiltration, neuroinflammation, neuronal cell death, facial nucleus, axon regeneration
MeSH terms
Animals, Axons, Cell Count, Cells, Cultured, Disease Models, Animal, Facial Nerve, Facial Nerve Diseases, Humans, Mice, Inbred ICR, NAD, Nerve Degeneration, Mice, Knockout, Dietary Supplements, Axotomy, Mice, ADP-ribosyl Cyclase 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deletion of CD38 and supplementation of NAD+ attenuate axon degeneration in a mouse facial nerve axotomy model. https://app.cochat.ai/papers/10.1038/s41598-020-73984-3
The paper
Takaso, Y., Noda, M., Hattori, T., Roboon, J., Hatano, M., Sugimoto, H., Brenner, C., Yamamoto, Y., Okamoto, H., Higashida, H., Ito, M., Yoshizaki, T., & Hori, O. (2020). Deletion of CD38 and supplementation of NAD+ attenuate axon degeneration in a mouse facial nerve axotomy model. Scientific Reports. https://doi.org/10.1038/s41598-020-73984-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.